GlaxoSmithKline discontinues Flovent Rotadisk
Executive Summary
GlaxoSmithKline is discontinuing Flovent Rotadisk (fluticasone propionate inhalation powder). The decision was based "on a careful assessment of the product's current manufacturing process needs, current low product volumes utilized, and the availability of alternative therapies for the treatment of asthma," the company says in a 1"Dear Doctor" letter. Supplies of Flovent Rotadisk, which represents less than 1% of the franchise's sales, will begin to be depleted in September. GSK's letter highlights the continued availability of Flovent inhalation aerosol. Flovent is also approved, but not marketed, in Diskus and HFA formulations...